Funding news
Ollin Biosciences logo

Ollin Biosciences Closes $330.

Recently funded · $330.0M Series bHospitals and Health CareUSView source

Get the full Ollin Biosciences company profile

Access contacts, investors, buying signals & more

Open in Dashboard

Ollin Biosciences, a clinical-stage biopharmaceutical company dedicated to acquiring and developing therapies for vision-threatening diseases, has secured a substantial $330.0M in Series b funding. The capital infusion will further its mission to bring best-in-disease treatments to market.

With a differentiated pipeline and a world-class team, Ollin aims to redefine what’s possible in ophthalmology. This latest round underscores strong investor confidence in the company's innovative approach to tackling critical vision impairments.

This Wednesday, two leading #antibodydrugconjugates have secured important new European approvals, with#Astellas' #Padcev cleared in bladder cancer and#Gilead's #Trodelvy winning another nod in triple-negative breast cancer.

In other news today,#UK #regulator #NICE has recommended#Regeneron's immunotherapy #Libtayo for advanced#cervicalcancer, making the treatment available to eligible patients through the #NHS in England and Wales.Meanwhile, a new report from#EFPIA warns that#access to innovative medicines is worsening across#Europe, adding fresh pressure to debates around drug #pricing, #reimbursement, and healthcar

Unlock the full source

CEO quotes, investor details and growth metrics

Start free trial

Other United States companies recently funded

View all

Biggest recent Biotechnology rounds

Largest funding rounds in Biotechnology on Signalbase right now.

#CompanyAmount
1
Shockwave Medical logo

Shockwave Medical

United States

$13.1B
2
NeuroEM Therapeutics logo

NeuroEM Therapeutics

United States

$7.2B
3
Illumina logo

Illumina

United States

$7.1B
4
GRAIL logo

GRAIL

United States

$7.1B
5
RemeGen Biosciences logo

RemeGen Biosciences

United States

$5.6B

Other recent Series b rounds

Companies that recently closed a Series b round.

#CompanyAmount
1
ElevateAI logo

ElevateAI

$100.0M
2
xCures Inc. logo

xCures Inc.

United States

$46.0M
3
PROPHESEE logo

PROPHESEE

France

$20.0M
4
Isometric logo

Isometric

United Kingdom

$400.0M
5
SWARM logo

SWARM

United States

$22.0M